4//SEC Filing
GRIMALDI CLAUDIA 4
Accession 0001185185-23-000672
CIK 0001326205other
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 9:25 PM ET
Size
17.7 KB
Accession
0001185185-23-000672
Insider Transaction Report
Form 4
GRIMALDI CLAUDIA
Director
Transactions
- Exercise/Conversion
Common Stock
2023-03-31+58,334→ 700,488 total - Exercise/Conversion
Restricted Stock Units
2023-03-31−83,333→ 83,833 total→ Common Stock (83,333 underlying) - Exercise/Conversion
Common Stock
2023-03-31+83,333→ 642,154 total - Award
Restricted Stock Units
2022-05-25+175,000→ 175,000 total→ Common Stock (175,000 underlying) - Award
Restricted Stock Units
2023-06-20+300,000→ 300,000 total→ Common Stock (300,000 underlying) - Exercise/Conversion
Restricted Stock Units
2023-03-31−58,334→ 116,666 total→ Common Stock (58,334 underlying) - Award
Restricted Stock Units
2023-06-20+380,000→ 380,000 totalExp: 2033-03-31→ Common Stock (380,000 underlying)
Footnotes (5)
- [F1]On July 19, 2021, the Reporting Person was granted RSUs equally vesting over three years starting March 2022.
- [F2]On May 25, 2022, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2023.
- [F3]On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2024.
- [F4]On June 20, 2023, the Reporting Person was granted RSUs subject to vesting according to specific milestones set by the Company's Board of Directors. The RSUs vest when milestones are achieved.
- [F5]Each restricted stock unit represents a right to receive one share of IGC common stock.
Documents
Issuer
IGC Pharma, Inc.
CIK 0001326205
Entity typeother
Related Parties
1- filerCIK 0001745853
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 9:25 PM ET
- Size
- 17.7 KB